Sort
326,823 grants matching “clinical trial”
Clinical Trials of Parainfluenza and Respiratory Syncytial Virus Vaccines
$2,209,409Brian Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Chicago WIHS Consortium V (CWC)
$2,209,223Mardge H Cohen · Hektoen Institute For Medical Research · U01 · FY2016 · AI
The Pacific Northwest Prostate Cancer SPORE
$2,209,204Peter S Nelson · Fred Hutchinson Cancer Center · P50 · FY2024 · CA
The Johns Hopkins Translational Science Team for the ET-CTN
$2,209,015Michael A. Carducci · Johns Hopkins University · UM1 · FY2018 · CA
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies
$2,208,763Pamela J Bjorkman · California Institute Of Technology · P01 · FY2023 · AI
Flavivirus Infections: Pathogenesis and Prevention
$2,208,691Alan L Rothman · Univ Of Massachusetts Med Sch Worcester · P01 · FY2009 · AI
Alzheimer's Disease Research Center
$2,208,597Mary Sano · Icahn School Of Medicine At Mount Sinai · P50 · FY2018 · AG
Molecular Genetics Of Heritable Human Disorders
$2,208,533Janice Chou · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2024 · HD
Developmental and Hyperactive Ras Tumor (DHART) SPORE
$2,208,392David W. Clapp · Indiana University Indianapolis · U54 · FY2024 · CA
PNA5: A Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Vascular Dementia and Alzheimer's Disease Related Dementia: an FDA required Toxicology Study
$2,208,081Meredith Hay · University Of Arizona · U01 · FY2023 · AG
SPORE: Targeted Therapies for Glioma
$2,207,927Tracy T Batchelor · Brigham And Women'S Hospital · P50 · FY2023 · CA
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
$2,207,890Roy S Herbst · Yale University · P50 · FY2020 · CA
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$2,207,796Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2012 · CA
IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
$2,207,796Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA
Ancillary: Inflammation/Oxidation, Omega-3's, & Post-Op AFiB & Cognitive Decline
$2,207,492Dariush Mozaffarian · Brigham And Women'S Hospital · RC2 · FY2009 · HL
AAV Gene Therapy for Lipid Disorders
$2,207,309James M Wilson · University Of Pennsylvania · P01 · FY2019 · HL
Center for the Biologic Basis of Oral/Systemic Disease (CBBOSD)
$2,207,122Jeffrey L Ebersole · University Of Kentucky · P20 · FY2010 · RR
Alzheimer's Prevention Initiative ADAD Colombia Trial
$2,207,066Eric M Reiman · Banner Health · R01 · FY2018 · AG
Optimizing Care for Older Adults through Thyroid Hormone Deprescribing
$2,206,807Maria Papaleontiou · University Of Michigan At Ann Arbor · RF1 · FY2025 · AG
Biomarkers of Cognitive Decline among Normal Individuals: the BIOCARD cohort
$2,206,720Marilyn S Albert · Johns Hopkins University · U01 · FY2012 · AG
Translational Research to Prevent and Control Global Infectious Diseases (Translational Global Infectious Diseases Research Center, TGIR).
$2,206,711Beth Diane Kirkpatrick · University Of Vermont & St Agric College · P20 · FY2020 · GM
DTMI-Center for Thrombotic and Hemostatic Disorders
$2,206,682Bruce Alan Sullenger · Duke University · U54 · FY2013 · HL
The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular Carcinoma
$2,206,679Laura Beretta · University Of Tx Md Anderson Can Ctr · P50 · FY2023 · CA
Alzheimer's Disease Cooperative Study
$2,206,643Howard Feldman · University Of California, San Diego · U19 · FY2017 · AG
Effects of Coenzyme Q10 in Parkinson Disease-Phase 3
$2,206,627Weill Medical College Of Cornell Univ · U01 · FY2005 · NS